These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33095334)
1. [Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa]. Oymanns M; Kreuter A; Assaf C Hautarzt; 2021 May; 72(5):435-438. PubMed ID: 33095334 [TBL] [Abstract][Full Text] [Related]
2. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne. Vinkel C; Thomsen SF Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207 [TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Shenefelt PD Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710 [TBL] [Abstract][Full Text] [Related]
4. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier. Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847 [No Abstract] [Full Text] [Related]
5. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature]. García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015 [TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? Garzorz N; Papanagiotou V; Atenhan A; Andres C; Eyerich S; Eyerich K; Ring J; Brockow K J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):141-3. PubMed ID: 25070077 [No Abstract] [Full Text] [Related]
7. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa. Fischer AH; Jourabchi N; Khalifian S; Lazarus GS Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180 [TBL] [Abstract][Full Text] [Related]
8. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients. Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620 [TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab. Groleau PF; Grossberg AL; Gaspari AA Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210 [TBL] [Abstract][Full Text] [Related]
10. PASS Syndrome: An IL-1-Driven Autoinflammatory Disease. Leuenberger M; Berner J; Di Lucca J; Fischer L; Kaparos N; Conrad C; Hohl D; So A; Gilliet M Dermatology; 2016; 232(2):254-8. PubMed ID: 26919742 [TBL] [Abstract][Full Text] [Related]
11. Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa. Sun NZ; Ro T; Jolly P; Sayed CJ J Clin Aesthet Dermatol; 2017 Sep; 10(9):36-38. PubMed ID: 29344326 [TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1β). Jaeger T; Andres C; Grosber M; Zirbs M; Hein R; Ring J; Traidl-Hoffmann C Eur J Dermatol; 2013; 23(3):408-10. PubMed ID: 23816498 [No Abstract] [Full Text] [Related]
14. Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome. Saito N; Minami-Hori M; Nagahata H; Nozaki H; Iinuma S; Igawa S; Kanno K; Kishibe M; Kanazawa N; Ishida-Yamamoto A J Dermatol; 2018 Aug; 45(8):e213-e214. PubMed ID: 29575118 [No Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. Braun-Falco M; Kovnerystyy O; Lohse P; Ruzicka T J Am Acad Dermatol; 2012 Mar; 66(3):409-15. PubMed ID: 21745697 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporin-responsive hidradenitis suppurativa. Buckley DA; Rogers S J R Soc Med; 1995 May; 88(5):289P-290P. PubMed ID: 7636825 [TBL] [Abstract][Full Text] [Related]
17. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review. Huang J; Tsang LS; Shi W; Li J Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426 [TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab. Fattore D; Pistone G; Bongiorno MR G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847 [No Abstract] [Full Text] [Related]